GSE204753
Transcriptomic analysis of sotorasib-resistant patient-derived xenograft (PDX) lung tumor cells
To characterize sotorasib resistance in lung adenocarcinomas (LUAD), we implanted pieces derived from a patient-derived KRAS-G12C positive xenograft (PDX) lung tumor model in immunocompromised mice Overall design: Gene expression profiling analysis of sotorasib-resistant lung tumors using patient-derived xenograft (PDX)